Found: 6
Select item for more details and to access through your institution.
Evaluating Co-primary Endpoints Collectively in Clinical Trials.
- Published in:
- Biometrical Journal, 2009, v. 51, n. 1, p. 137, doi. 10.1002/bimj.200710497
- By:
- Publication type:
- Article
Discordant responses of plasma low-density lipoprotein cholesterol and lipoprotein(a) to alirocumab: A pooled analysis from 10 ODYSSEY Phase 3 studies.
- Published in:
- European Journal of Preventive Cardiology, 2021, v. 28, n. 8, p. 816, doi. 10.1177/2047487320915803
- By:
- Publication type:
- Article
Intensity of statin treatment after acute coronary syndrome, residual risk, and its modification by alirocumab: insights from the ODYSSEYOUTCOMES trial.
- Published in:
- European Journal of Preventive Cardiology, 2021, v. 28, n. 1, p. 33, doi. 10.1177/2047487320941987
- By:
- Publication type:
- Article
Effect of alirocumab on major adverse cardiovascular events according to renal function in patients with a recent acute coronary syndrome: prespecified analysis from the ODYSSEY OUTCOMES randomized clinical trial.
- Published in:
- European Heart Journal, 2020, v. 41, n. 42, p. 4114, doi. 10.1093/eurheartj/ehaa498
- By:
- Publication type:
- Article
Use of the Wei-Lin-Weissfeld method for the analysis of a recurring and a terminating event.
- Published in:
- 1997
- By:
- Publication type:
- journal article
On the Relationship between Directional and Omnibus Statistical Tests.
- Published in:
- Scandinavian Journal of Statistics, 2006, v. 33, n. 2, p. 239, doi. 10.1111/j.1467-9469.2005.00489.x
- By:
- Publication type:
- Article